PHLPP1 and cancer: Both microautophagy and CMA might also contribute to cancer development; for example, LAMP2A is highly increased in malignant tumors, including GBM, and it is a predictor of poor prognosis [38], while the downregulation of other CMA proteins, such as PHLPP1, has been found in several tumors [39].